AIM
AZN icon

Achmea Investment Management’s AstraZeneca AZN Stock Holding History

Achmea Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.7M Sell
313,557
-16,584
-5% -$3.12M 1.47% 12
2026
Q1 		$64M Buy
+330,141
New +$63.7M 1.69% 11

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Achmea Investment Management's AZN Position: Q2 2026 in Review

Achmea Investment Management reduced its AstraZeneca (AZN) stake by 5% in Q2 2026, selling an estimated $3.12M and leaving 313,557 shares worth $58.7M. The position accounts for 1.47% of the portfolio, ranked #12.

Achmea Investment Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $64M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Achmea Investment Management held 313,557 shares of AstraZeneca worth $58.7M as of Q2 2026.
  • Achmea Investment Management sold 16,584 AstraZeneca shares in Q2 2026, an estimated $3.12M.
  • AstraZeneca made up 1.47% of Achmea Investment Management's portfolio in Q2 2026, its #12 holding.
  • Achmea Investment Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • Achmea Investment Management's AstraZeneca position peaked at $64M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.